156 Ces Urol 2024; 28(3): 141–157 PŘEHLEDOVÉ ČLÁNKY 43. Daudon M, Bouzidi H, Bazin D. Composition and morphology of phosphate stones and their relation with etiology. Urol Res [Internet]. 2010; 38(6): 459–67. Available from: http://dx.doi.org/10.1007/s00240-0100320-3. 44. Pak CYC, Poindexter JR, Peterson RD, Heller HJ. Biochemical and physicochemical presentations of patients with brushite stones. J Urol [Internet]. 2004 [cited 2024 Aug 8]; 171(3): 1046–9. Available from: https://pubmed.ncbi.nlm.nih.gov/14767267/. 45. Peerapen P, Thongboonkerd V. Kidney stone prevention. Adv Nutr [Internet]. 2023; 14(3): 555–69. Available from: http://dx.doi.org/10.1016/j.advnut.2023. 03. 002. 46. Low phosphate diet. [Internet]. Cambridge University Hospitals. [cited 2024 Aug 8]. Available from: https://www.cuh.nhs.uk/patient-information/low-phosphate-diet. 47. Wagner CA, Mohebbi N. Urinary pH and stone formation. J Nephrol. 2010; 23(Suppl 16): S165–9. 48. Coe F. Brushite: Key to calcium stone prevention [Internet]. Uchicago.edu. [cited 2024 Aug 8]. Available from: https://kidneystones.uchicago.edu/2020/12/26/why-ss-for-calcium-phosphate-is-so-important. 49. Klee LW, Brito CG, Lingeman JE. Clinical implications of brushite calculi. J Urol [Internet]. 1991; 145(4): 715–8. Available from: http://dx.doi.org/10.1016/s0022-5347(17)38432-x. 50. Meng M. Struvite and staghorn calculi treatment & management [Internet]. Medscape.com. 2024 [cited 2024 Aug 8]. Available from: https://emedicine.medscape.com/article/439127-treatment. 51. Gettman MT, Segura JW. Struvite stones: Diagnosis and current treatment concepts. J Endourol [In‑ ternet]. 1999; 13(9): 653–8. Available from: http://dx.doi.org/10.1089/end.1999. 13. 653. 52. Karki N, Leslie SW. Struvite and Triple Phosphate Renal Calculi. StatPearls Publishing; 2023. 53. Grases F, Costa-Bauzá A, Gomila I, Ramis M, García-Raja A, et al. Urinary pH and renal lithiasis. Urol Res [Internet]. 2012; 40(1): 41–6. Available from: http://dx.doi.org/10.1007/s00240-011-0389-3. 54. Bose A, Bushinsky DA. Nephrolithiasis, nephrocalcinosis, and hypercalciuria. In: Chronic Renal Disease. Elsevier; 2020; p. 1103–22. 55. Lubawy M, Formanowicz D. High-fructose diet–induced hyperuricemia accompanying metabolic syndrome-mechanisms and dietary therapy proposals. Int J Environ Res Public Health [Internet]. 2023; 20(4): 3596. Available from: http://dx.doi.org/10.3390/ijerph20043596. 56. Yamanaka H. Alcohol ingestion and hyperuricemia. Nihon Rinsho [Internet]. 1996 [cited 2024 Aug 8]; 54(12). Available from: https://pubmed.ncbi.nlm.nih.gov/8976122/. 57. Powell CR, Stoller ML, Schwartz BF, et al. Impact of body weight on urinary electrolytes in urinary stone formers. Urology [Internet]. 2000; 55(6): 825–30. Available from: http://dx.doi.org/10.1016/s00904295(99)00617-2. 58. Cameron MA, Maalouf NM, Adams-Huet B, et al. Urine composition in type 2 diabetes: Predisposition to uric acid nephrolithiasis. J Am Soc Nephrol [Internet]. 2006; 17(5): 1422–8. Available from: http://dx.doi. org/10.1681/asn.2005121246. 59. Daudon M, Traxer O, Conort P, et al. Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol [Internet]. 2006; 17(7): 2026–33. Available from: http://dx.doi.org/10.1681/asn.2006030262. 60. Rodgers A, Allie-Hamdulay S, Jackson G. Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor. Nephrol Dial Transplant [Internet]. 2006; 21(2): 361–9. Available from: http://dx.doi.org/10.1093/ndt/gfi211. 61. Sadiq S, Cil O. Cystinuria: An overview of diagnosis and medical management. Turk Arch Pediatrics [Internet]. 2022; 57(4): 377–84. Available from: http://dx.doi.org/10.5152/turkarchpediatr.2022.22105. 62. Cafasso J. Cystinuria [Internet]. Healthline. 2018 [cited 2024 Aug 8]. Available from: https://www.heal‑ thline.com/health/cystinuria. 63. Kowalczyk NS, Zisman AL. Cystinuria: Review of a life-long and frustrating disease. Yale J Biol Med. 2021; 94(4): 681–6.
RkJQdWJsaXNoZXIy NDA4Mjc=